Sysmex : Financial Data(

FINANCIAL DATA (IFRS)

2nd Quarter

Fiscal Year Ending March 31, 2023

[202332]

April 1, 2022 September 30, 2022

CONTENTS

Financial Summary (Consolidated)	1
		Consolidated statement of financial position	3
	Consolidated statement of income	5
		Consolidated statement of cash flows	6
		Net Sales by Destination,Business and Product type	8
		Net Sales by Destination and Business	9
		Net Sales by Destination and Product type	12
		Net Sales and Operating Income (Loss) by Geographical Region	13
Associated Data	14
Corporate Data	15

Notes

20233

In the second quarter of the fiscal year endinged March 31, 2023, Sysmex Pilot Co., Ltd. became a subsidiary.

2022320213In fiscal year ended March 31, 2022, Sysmex changed its accounting policy for configuration or customization costs in cloud computing contracts to recognize costs as expenses when services are received.

Comparisons with the fiscal year ended March 31, 2021 have been made using figures that have been retroactively adjusted for this change.

202331

In the first quarter of the fiscal year endinged March 31, 2023, Sysmex Astrego AB became a subsidiary.

201833

In the third quarter of the fiscal year ended March 31, 2018, the joint venture Sysmex bioMérieux Co., Ltd., was dissolved.

201831

In the first quarter of the fiscal year ended March 31, 2018, Oxford Gene Technology IP Limited became a subsidiary.

201731

In the first quarter of the fiscal year ended March 31, 2017, RIKEN GENESIS Co., Ltd., became a subsidiary.

20173IFRS 201731IFRS

From fiscal year ended March 31, 2017, Sysmex adopts IFRS and disclose financial information based on IFRS from the first three months of the fiscal year ended March 31, 2017.

Cautionary Notes

This material contains forward-looking statements about Sysmex Corporation and its group companies (the Sysmex Group). These forward-looking statements are based on current judgments and assumptions of the Sysmex Group in light of the information currently available to it, and involve known and unknown risks, uncertainties and other factors, including but not limited to: global economic conditions, competitive situations and changes in exchange rates. Such risks, uncertainties and other factors may cause our actual results, performance, achievements or financial position to be materially different from any future results, performance, achievements or financial position expressed or implied by these forward-looking statements.

1

										JPY million
					Fiscal Term	2019.3 2Q	2020.3 2Q	2021.3 2Q	2022.3 2Q	2023.3 2Q	2023.3
Item			Forecast
					Net sales	136,194	142,990	132,082	168,753	194,022	420,000
					Cost of sales	59,663	65,454	64,792	78,932	95,483	200,000
					Gross profit	76,531	77,535	67,289	89,821	98,538	220,000
					Selling, general and administrative expenses	39,788	40,031	38,078	44,524	52,982	112,500
					Research and development expenses	8,763	10,460	9,748	11,610	14,528	33,500
					Other operating income (expenses)	524	760	541	434	2,123	3,000
					Operating profit	28,503	27,803	20,004	33,251	33,150	77,000
					Profit	19,389	17,458	12,578	21,824	23,921		51,000
					Profit attributable to owners of the parent	19,473	17,593	12,653	21,924	23,989	51,000
					Diluted earnings per share( )	93.19	84.20	60.53	104.67	114.61	243.64
					Return on equity ROE	-	-	-	-	-	14.1
					Gross profit per net sales	56.2	54.2	50.9	53.2	50.8	52.4
					Operating profit to net sales	20.9	19.4	15.1	19.	17.1	18.3
					Profit attributable to owners of the parent to net sales	14.3	12.3	9.5	13.0	12.4		12.1
					R&D expenditure per net sales	6.4	7.3	7.4	6.9	7.5	8.0
					Fiscal Term	2019.3 FY	2020.3 FY	2021.3 FY	2022.3 FY	2023.3 2Q
Item
					Capital stock	12,654	12,877	13,229	14,112	14,194
					Number of outstanding stock excluding treasury stock (thousand shares)	208,708.2	208,819.7	208,996.3	209,210.1	209,227.7
					Total equity	265,182	278,347	306,089	349,053	380,388
					Total assets	346,775	389,291	424,895	483,707	511,230
					Equity attributable to owners of the parent to total assets	76.3	71.3	71.9	72.0	74.3
(	Equity attributable to owners of the parent per share	1,267.07	1,329.78	1,460.88	1,664.85	1,814.80
					Fiscal Term	2019.3 2Q	2020.3 2Q	2021.3 2Q	2022.3 2Q	2023.3 2Q
Item
					Net cash provided by (used in) operating activities	19,426	26,908	23,820	36,513	28,269
					Net cash provided by (used in) investment activities	22,729	9,057	15,104	14,541	25,831
					Net cash provided by (used in) financing activities	7,253	10,195	10,494	10,650	11,946
					Cash and cash equivalents at the end of the term	50,844	56,985	55,213	78,216	69,219

Capital Expenditure

	2019.3 2Q	2020.3 2Q	2021.3 2Q	2022.3 2Q	2023.3 2Q	2023.3
Item	Forecast
Capital expenditure	13,438	12,453	10,145	13,565	17,431	41,800
Depreciation and amortization	7,620	11,510	12,537	13,541	15,440	30,500

Includes both tangible and intangible assets

Business forecast was revised in November 2022.

Average Exchange Rate (Annual)

			Fiscal Term	2019.3 FY	2020.3 FY	2021.3 FY	2022.3 FY	2023.3
				Forecast
US	USD	(JPY)	110.9	108.7	106.1	112.4	139.5
		EUR	(JPY)	128.4	120.8	123.7	130.6	140.4
		CNY	(JPY)	16.5	15.6	15.7	17.5	19.9

Average Exchange Rate (Periods)

			Fiscal Term	2019.3 2Q	2020.3 2Q	2021.3 2Q	2022.3 2Q	2023.3 2Q
		Item
US	USD	(JPY)	110.3	108.6	106.9	109.8	13 .
		EUR	(JPY)	129.9	121.4	121.3	130.9	138.7
		CNY	(JPY)	16.8	15.7	15.3	17.0	19.

Business forecast was revised in November 2022.

2

3

Consolidated statement of financial position

Assets											%	JPY million	(Ratio %)
	2019.3 FY		2020.3 FY		2021.3 FY		2022.3 FY		2023.3 2Q
Item			Ratio		Ratio		Ratio			Ratio		Ratio	(Variance)
Current assets
Cash and cash equivalents	51,062		14.7	56,592	14.5	66,467	15.6	73,752		15.2	69,219	13.5		4,533
Trade and other receivables	84,247		24.3	85,650	22.0	100,641	23.7	118,697		24.5	116,230	22.7		2,467
Inventories	40,231		11.6	48,303	12.4	46,985	11.1	61,944		12.8	74,610	14.6		12,666
Other short-term financial assets	7,644		2.2	421	0.1	1,105	0.3	1,498		0.3	1,493	0.3		5
Income taxes receivable	412		0.1	546	0.1	909	0.2	470		0.1	581	0.1		111
Other current assets	11,824		3.4	14,191	3.6	14,723	3.5	18,728		3.9	19,667	3.8		939
Total current assets	195,423		56.4	205,704	52.8	230,833	54.3	275,092		56.9	281,801	55.1		6,709
Non-current assets
Property, plant and equipment	76,312		22.0	96,839	24.9	96,140	22.6	98,525		20.4	102,562	20.1		4,037
Goodwill	11,917		3.4	11,271	2.9	12,433	2.9	13,010		2.7	19,878	3.9		6,868
Intangible assets	33,037		9.5	39,543	10.2	46,840	11.0	57,260		11.8	64,392	12.6		7,132
Investments accounted for using the equity method	634		0.2	2,945	0.8	1,093	0.3	986		0.2	-	-		986
Trade and other receivables	12,202		3.5	12,845	3.3	15,202	3.6	16,403		3.4	17,793	3.5		1,390
Other long-term financial assets	7,050		2.0	6,192	1.6	7,945	1.9	9,157		1.9	9,426	1.8		269
Asset for retirement benefits	917		0.3	897	0.2	923	0.2	841		0.2	868	0.2		27
Other non-current assets	3,456		1.0	5,810	1.5	5,621	1.3	3,910		0.8	4,072	0.8		162
Deferred tax assets	5,823		1.7	7,240	1.9	7,860	1.9	8,520		1.8	10,434	2.0		1,914
Total non-current assets	151,352		43.6	183,586	47.2	194,061	45.7	208,614		43.1	229,429	44.9		20,815
Total assets	346,775		100.0	389,291	100.0	424,895	100.0	483,707		100.0	511,230	100.0		27,523